Determination of hypericin and hyperforin content in selected Jordanian Hypericum species

Industrial Crops and Products

Volumn 32, Issue 3, 2010, Pages 241-245

  Tawaha, Khaled ^a   Gharaibeh, Mohammad ^b   El Elimat, Tamam ^b   Alali, Feras Q ^b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

HPLC; Hyperforin; Hypericin; Hypericum; Standardization

Indexed keywords

AMMONIUM ACETATE; CHROMATOGRAPHY COLUMNS; CONCENTRATION RANGES; HPLC; HYPERFORINS; HYPERICIN CONTENTS; HYPERICINS; HYPERICUM; HYPERICUM SPECIES; MARKER COMPOUNDS; METHANOLIC EXTRACTS; MOBILE PHASE; PHOTODIODE ARRAY DETECTIONS; QUALITY EVALUATION; REFERENCE STANDARD; REVERSED-PHASE HPLC METHOD; SIMULTANEOUS ANALYSIS; ST. JOHN'S WORT; STANDARD CURVES; WAVELENGTH RANGES;

ACETONITRILE; AMMONIUM COMPOUNDS; COLUMN CHROMATOGRAPHY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL; STANDARDIZATION;

QUALITY CONTROL;

ANTIBIOTICS; BIOMARKER; CHROMATOGRAPHY; MEDICINAL PLANT; METHANOL; ORGANIC COMPOUND; SPECIES DIVERSITY; STANDARDIZATION; WAVELENGTH;

HYPERICUM; HYPERICUM EMPETRIFOLIUM; HYPERICUM TRIQUETRIFOLIUM;

EID: 77957240427     PISSN: 09266690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indcrop.2010.04.017     Document Type: Article

References (60)

1. Agostinis P., Vantieghem A., Merlevede W., deWitte P.A. Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol. 2002, 34:221-241.
2. Al-Eisawi D.M. Field Guide to Wild Flowers of Jordan and Neighbouring Countries 1998, Jordan Press Foundation Al-Rai, Amman.
3. Alali F., Tawaha K., Al-Eleimat T. Determination of hypericin content in Hypericum triquetrifolium Turra (Hypericaceae) growing wild in Jordan. Nat. Prod. Res. 2004, 18:147-151.
4. Ayan A.K., Cirak C. Variation of hypericins in Hypericum triquetrifolium Turra growing in different locations of Turkey during plant growth. Nat. Prod. Res. 2008, 22:1597-1604.
5. Barnes J., Anderson L., Phillipson J. St. John wort (Hypericum perforatum L.): a review of its chemistry pharmacology and clinical properties. J. Pharm. Pharmacol. 2001, 53:583-600.
6. Batanouny, K.H., 1999. Wild Medicinal Plants in Egypt. Academy of Scientific Research and Technology, Egypt, International Union for Conservation (IUCN) with Support of the Swiss Development Co-operation (SDC).
7. Beerhues L. Molecules of interest hyperforin. Phytochemistry 2006, 67:2201-2207.
8. Bergonzi M.C., Bilia A.R., Gallori S., Guerrini D., Vincieri F.F. Variability in the content of the constituents of Hypericum perforatum L. and some commercial extracts. Drug Dev. Ind. Pharm. 2001, 27:491-497.
9. Brockmann H., Haschad M.N., Maier K., Pohl F. Über das Hypericin, den photodynamisch wirksamen Farbstoff aus Hypericum perforatum. Naturwissenschaften 1939, 27:550.
10. Brockmann H., Falkenhausen E.H., Dorlares A. Die Konstitution des Hypericins. Naturwissenschaften 1950, 37:540-545.
11. Butterweck V., Korte B., Winterhoff H. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry 2001, 34S:2-7.
12. Butterweck V., Bockers T., Korte B., Wittkowski W., Winterhoff H. Long-term effects of St. John's wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res. 2002, 930:21-29.
13. Bystrov N.S., Chernov B.K., Dobrynin V.N., Kolosov M.N. The structure of hyperforin. Tetrahedron Lett. 1975, 32:2791-2794.
14. Chatterjee S.S., Bhattacharya S.K., Wonnemann M., Singer A., Muller W.E. Hyperforin as a possible anti-depressant component of Hypericum extracts. Life Sci. 1998, 63:499-510.
15. Çirak C., Radusiene J., Janulis V., Ivanauskas L. Pseudohypericin and hyperforin in Hypericum perforatum from Northern Turkey: variation among populations, plant parts and phenological stages. J. Integr. Plant Biol. 2008, 50:575-580.
16. Danin A. Contributions to the flora of Jordan: new and interesting plants from Dana Nature Reserve, SW Jordan. Willdenowia 1997, 27:161-175.
17. Dogrukol-Ak D., Kirimer N., Tuncel M., Aboul-Enein H.Y. Determination of rutin in Hypericum perforatum extract by capillary electrophoresis. Anal. Lett. 2001, 34:185-191.
18. Draves D.H., Walker S.E. Determination of hypericin and pseudohypericin in pharmaceutical preparations by liquid chromatography with fluorescence detection. J. Chromatogr. B 2000, 749:57-66.
19. Eggelkraut-Gottanka S.V., Abu-Abed S., Muller W., Schmidt P. Quantitative analysis of the active components and the by-products of eight dry extracts of Hypericum perforatum L. (St John's wort). Phytochem. Anal. 2002, 13:170-176.
20. Erdelmeier C.A.J., Klessing K., Renzl S., Hauer H. New hyperforin analogues from Hypericum perforatum and a stable dicyclohexylammonium salt of hyperforin. 2000 Years of Natural Products Research - Past, Present and Future 1999, 432. T.J.C. Luijendijk, R. Verpoorte (Eds.).
21. Ernst E. Hypericum. The Genus Hypericum 2003, Taylor & Francis, Inc., London.
22. Gronquist M., Bezzerides A., Attygalle A., Meinwald J., Eisner M., Eisner T. Attractive and defensive functions of the ultraviolet pigments of a flower (Hypericum calycinum). Proc. Natl. Acad. Sci. 2001, 98:13745-13750.
23. Guedes R.C., Eriksson L.A. Theoretical study of hypericin. J. Photochem. Photobiol. A: Chem. 2005, 172:293-299.
24. Holt R.M., Newman M.J., Pullen F.S., Richards D.S., Swanson A.G. High-performance liquid chromatography/NMR spectrometry/mass spectrometry: further advances in hyphenated technology. J. Mass Spectrom. 1997, 32:64-70.
25. Hu L.H., Sim K.Y., Sampsoniones A.-M. A unique family of caged polyprenylated benzoylphloroglucinol derivatives, from Hypericum sampsonii. Tetrahedron 2000, 56:1379-1386.
26. Jager L.S.D., Perfetti G.A., Diachenko G.W. Liquid chromatographic determination of St. John's wort components in functional foods. J. AOAC Int. 2004, 87:1042-1048.
27. Kitanov G.M. Hypericin and pseudohypericin in some Hypericum species. Biochem. Syst. Ecol. 2001, 29:171-178.
28. Kubin A., Wierrani F., Burner U., Alth G., Grünberger W. Hypericin - the facts about a controversial agent. Curr. Pharm. Des. 2005, 11:233-253.
29. Laakmann G., Schule C., Baghai T., Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998, 31:54-59.
30. Lang F., Biber A., Erdelmeier C. Hyperforin in Johanniskraut-Droge, -Extrakten und -Praparaten. Pharm. Unserer Zeit 2002, 5:512-514.
31. Li W., Fitzloff J.F. High performance liquid chromatographic analysis of St. John's Wort with photodiode array detection. J. Chromatogr. B 2001, 765:99-105.
32. Liu F.F., Ang C.Y.W., Heinze T.M., Rankin J.D., Beger R.D., Freeman J.P., LayJr J.O. Evaluation of major active components in St. John's Wort dietary supplements by high-performance liquid chromatography with photodiode array detection and electrospray mass spectrometric confirmation. J. Chromatogr. A 2000, 888:85-92.
33. Liu F.F., Pan C., Drumm P., Ang C.Y.W. Liquid chromatography mass spectrometry studies of St. John's wort methanol extraction: active constituents and their transformation. J. Pharm. Biomed. Anal. 2005, 37:303-312.
34. Medina M.A., Martínez-Poveda B., Amores-Sánchez M.I., Quesada A.R. Minireview. Hyperforin: more than an antidepressant bioactive compound?. Life Sci. 2006, 79:105-111.
35. Meruelo D., Lavie G., Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 1988, 85:5230-5234.
36. Moore L.B., Goodwin B., Jones S.A., Wisely G.B., Serabjit-Singh C.J., Willson T.M., Collins J.L., Kliewer S.A. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. 2000, 97:7500-7502.
37. Mulinacci N., Bardazzi C., Romani A., Pinelli P., Vincieri F.F., Costantini A. HPLC-DAD and TLC-Densitometry for quantification of hypericin in Hypericum perforatum L. Extracts. Chromatographia 1999, 49:197-202.
38. Muller W.E., Singer A., Wonnemann M., Hafner U., Rolli M., Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry 1998, 31S:16-21.
39. Muller W.E., Singer A., Wonnemann M. Hyperforin anti-depressant activity by a novel mechanism of action. Pharmacopsychiatry 2001, 34S:98-102.
40. Muller W.E. Current St. John's wort research from mode of action to clinical efficacy. Pharmacol. Res. 2003, 47:101-109.
41. Nahrstedt A., Butterweck V. Biologically active and other chemical constituents of the herb Hypericum perforatum L. Pharmacopsychiatry 1997, 30(Suppl.):129-134.
42. Pellati F., Benvenuti S., Melegari M. Chromatographic performance of a new polar poly(ethylene glycol) bonded phase for the phytochemical analysis of Hypericum perforatum L. J. Chromatogr. A 2005, 1088(1-2):205-217.
43. Peng Y.Y., Yuan J.J., Ye J.N. Determination of active components in St. John's wort (Hypericum perforatum) by capillary electrophoresis with electrochemical detection. Electroanalysis 2005, 17:1091-1096.
44. Pietta P., Gardana C., Pietta A. Comparative evaluation of St. John's wort from different Italian regions. Il Farmaco 2001, 56:491-496.
45. Repcak M., Martonfi P. The localization of secondary substances in Hypericum perforatum flowers. Biologia 1997, 52:91-94.
46. Riedel K.D., Rieger K., Martin-Facklam M., Mikus G., Haefeli W.E., Burhenne J. Simultaneous determination of hypericin and hyperforin in human plasma with liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2004, 813:27-33.
47. Robson N. Hypericum botany. Hypericum: the Genus Hypericum 2003, 196-241. Taylor and Francis, New York. E. Ernst (Ed.).
48. Sakar M., Tamer A. Antimicrobial activity of different extracts from Hypericum species. Fitoterapia 1990, 61:464-466.
49. Schempp C.M., Pelz K., Wittmer A., Schopf E., Simon J.C. Antibacterial activity of hyperforin from St. John's wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. Lancet 1999, 353:2129.
50. Schempp C.M., Kirkin V., Simon-Haarhaus B., Kersten A., Kiss J., Termeer C.C., Gilb B., Kaufmann T., Borner C., Sleeman J.P., Simon J.C. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis. Oncogene 2002, 21:1242-1250.
51. +. J. Pharmacol. Exp. Ther. 1999, 290:1363-1368.
52. Sirvent M.T., Walker L., Vance N., Gibson D.M. Variation in hypericins from wild populations of Hypericum perforatum L. in the Pacific Northwest of the USA. Econ. Bot. 2002, 56:41-48.
53. Smelcerovic A., Spiteller M. Phytochemical analysis of nine Hypericum L. species from Serbia and the F.Y.R. Macedonia. Pharmazie 2006, 61:251-252.
54. Southwell I.A., Campbell M.H. Hypericin content variation in Hypericum perforatum in Australia. Phytochemistry 1991, 30:475-478.
55. Tolonen A., Uusitalo J., Hohtola A., Jalonen J. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2002, 16:396-402.
56. Treiber K., Singer A., Henke B., Muller W.E. Hyperforin activates nonselective cation channels (NSCCs). Br. J. Pharmacol. 2005, 145:75-83.
57. Umek A., Kreft S., Kartnig T., Heydel B. Quantitative phytochemical analyses of six Hypericum species growing in Slovenia. Planta Med. 1999, 65:388-390.
58. Wolfender J.L., Rodriguez S., Hostettmann K. Liquid chromatography coupled to mass spectrometry and nuclear magnetic resonance spectroscopy for the screening of plant constituents. J. Chromatogr. A 1998, 794:299-316.
59. Xenophontos M., Stavropoulos I., Avramakis E., Navakoudis E., Dornemann D., Kotzabasis K. Influence of the developmental stage on the (proto)-hypericin and (proto)pseudohypericin levels of Hypericum plants from Crete. Planta Med. 2007, 73:1309-1315.
60. Xenophontos M., Stavropoulos I., Avramakis E., Navakoudis E., Dornemann D., Kotzabasis K. Influence of the habitat altitude on the (proto)hypericin and (proto)pseudohypericin levels of hypericum plants from Crete. Planta Med. 2008, 74:1496-1503.